Edoxaban does not improve outcomes in patients with atrial high-rate episodes
1. In this randomized controlled trial, edoxaban did not significantly reduce the incidence of a composite of cardiovascular death, stroke, ...
1. In this randomized controlled trial, edoxaban did not significantly reduce the incidence of a composite of cardiovascular death, stroke, ...
Click to read the study in The New England Journal of Medicine ©2023 2 Minute Medicine, Inc. All rights reserved. ...
1. In this population-based cohort study, apixaban was associated with a lower risk of gastrointestinal bleeding (GIB) as compared to ...
Click to read this study in JAMA Network Open.
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular ...
1. Low dose edoxaban was superior to placebo in preventing stroke or systemic embolism for very elderly patients with nonvalvular ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.